Muhammad Zaki Hidayatullah Fadlullah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Muhammad Zaki Hidayatullah Fadlullah has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Har Yip
Breast Centre, PJ Integrated Centre for Advanced Surgery and Oncology (PICASO Hospital) University Malaya Kuala Lumpur Malaysia
1 shared publication - Meow-Keong Thong
M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Selangor, Malaysia
1 shared publication - Nur Aishah Taib
Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication - Pei Sze Ng
Cancer Research Malaysia
1 shared publication - Sheau Yee Lee
Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia
1 shared publication - Soo-Hwang Teo
Cancer Research Malaysia
1 shared publication
Latest Publications
- 3 February 2016
- Published by Wiley in Clinical Genetics
- Vol. 90 (4) , 315-323
Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing
Although an association between protein‐truncating variants and breast cancer risk has been established for 11 genes, only alterations in BRCA1, BRCA2, TP53 and PALB2 have been reported in Asian populations. Given that the age of onset of breast cancer is lower in Asians, it is estimated that inherited predisposition to breast cancer may be more significant. To determine the potential utility of panel testing, we investigated the prevalence of germline alterations in 11 established and 4 likely breast cancer genes in a cross‐sectional hospital‐based cohort of 108 moderate to high‐risk breast cancer patients using targeted next generation sequencing. Twenty patients (19%) were identified to carry deleterious mutations, of whom 13 (12%) were in the BRCA1 or BRCA2, 6 (6%) were in five other known breast cancer predisposition genes and 1 patient had a mutation in both BRCA2 and BARD1. Our study shows that BRCA1 and BRCA2 account for the majority of genetic predisposition to breast cancer in our cohort of Asian women. Although mutations in other known breast cancer genes are found, the functional significance and breast cancer risk have not yet been determined, thus limiting the clinical utility of panel testing in Asian populations.
- 3 February 2016
- Published by Wiley in Clinical Genetics
- Vol. 90 (4) , 315-323
Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing
Although an association between protein‐truncating variants and breast cancer risk has been established for 11 genes, only alterations in BRCA1, BRCA2, TP53 and PALB2 have been reported in Asian populations. Given that the age of onset of breast cancer is lower in Asians, it is estimated that inherited predisposition to breast cancer may be more significant. To determine the potential utility of panel testing, we investigated the prevalence of germline alterations in 11 established and 4 likely breast cancer genes in a cross‐sectional hospital‐based cohort of 108 moderate to high‐risk breast cancer patients using targeted next generation sequencing. Twenty patients (19%) were identified to carry deleterious mutations, of whom 13 (12%) were in the BRCA1 or BRCA2, 6 (6%) were in five other known breast cancer predisposition genes and 1 patient had a mutation in both BRCA2 and BARD1. Our study shows that BRCA1 and BRCA2 account for the majority of genetic predisposition to breast cancer in our cohort of Asian women. Although mutations in other known breast cancer genes are found, the functional significance and breast cancer risk have not yet been determined, thus limiting the clinical utility of panel testing in Asian populations.